Form 8-K - Current report:
SEC Accession No. 0001493152-22-008253
Filing Date
2022-03-31
Accepted
2022-03-31 07:42:55
Documents
14
Period of Report
2022-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36785
2 ex99-1.htm EX-99.1 76965
3 ex99-1_001.jpg GRAPHIC 3790
  Complete submission text file 0001493152-22-008253.txt   304111

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20220331.xsd EX-101.SCH 3063
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20220331_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20220331_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 22789147
SIC: 2834 Pharmaceutical Preparations